Attached files

file filename
EX-32.2 - EXHIBIT 32.2 CERTFICATION OF THE CFO SECTION 906 - CELGENE CORP /DE/ex322certificationofthecfo.htm
EX-32.1 - EXHIBIT 32.1 CERTIFICATION OF THE CEO SECTION 906 - CELGENE CORP /DE/ex321certificationoftheceo.htm
EX-31.2 - EXHIBIT 31.2 CERTFICATION OF THE CFO SECTION 302 - CELGENE CORP /DE/ex312certificationofthecfo.htm
EX-31.1 - EXHIBIT 31.1 CERTIFICATION OF THE CEO SECTION 302 - CELGENE CORP /DE/ex311certificationoftheceo.htm
EX-24.1 - EXHIBIT 24.1 POWER OF ATTORNEY - CELGENE CORP /DE/ex241powerofattorney201612.htm
EX-21.1 - EXHIBIT 21.1 LIST OF SUBSIDIARIES - CELGENE CORP /DE/ex211listofsubsidiaries201.htm
EX-10.23 - EXHIBIT 10.23 FORM OF PERFORMANCE STOCK UNIT AGREEMENT - CELGENE CORP /DE/ex1023formofperformancesto.htm
EX-10.19 - EXHIBIT 10.19 LETTER AGREEMENT WITH RUPERT VESSEY - CELGENE CORP /DE/ex1019letteragreementwithr.htm
EX-10.17 - EXHIBIT 10.17 FORM OF RESTRICTED STOCK UNIT AGREEMENT - CELGENE CORP /DE/ex1017formofrestrictedstoc.htm
EX-10.16 - EXHIBIT 10.16 FORM OF STOCK OPTION AGREEMENT - CELGENE CORP /DE/ex1016formofstockoptionagr.htm
10-K - 10-K - CELGENE CORP /DE/a2016123110k.htm


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors
Celgene Corporation:

We consent to the incorporation by reference in the registration statements (Nos. 333-70083, 333-91977, 333-39716, 333-65908, 333-107980, 333-126296, 333-138497, 333-152655, 333-160955, 333-177669, 333-184634, 333-191996, 333-199638, 333-207840 and 333-212728) on Form S-8 and in the registration statements (Nos. 333-02517, 333-32115, 333-52963, 333-87197, 333-93759, 333-107977, 333-107978 and 333-214279) on Form S-3 of Celgene Corporation of our reports dated February 10, 2017, with respect to the consolidated balance sheets of Celgene Corporation and subsidiaries as of December 31, 2016 and 2015, and the related consolidated statements of income, comprehensive income, cash flows, and stockholders' equity for each of the years in the three-year period ended December 31, 2016, the related consolidated financial statement schedule, and the effectiveness of internal control over financial reporting as of December 31, 2016, which reports appear in the December 31, 2016 annual report on Form 10-K of Celgene Corporation and subsidiaries.
  

/s/ KPMG LLP
Short Hills, New Jersey
February 10, 2017